Clinical Trial Update: Safety and Tolerability of SPD476 in Maintaining Remission in Patients With Ulcerative Colitis. [Phase 3]

View source ↗

Summary

Phase 3 trial update on SPD476 assessing safety and tolerability for maintaining remission in ulcerative colitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• SPD476

Snippet

Sponsor: Shire | Conditions: Colitis, Ulcerative | Phase 3 | Status: COMPLETED